Photo of: Adrian Harel

Dr. Adrian Harel

View Title...

Meditor Pharmaceuticals Ltd.
Adrian's profile was created using:
Sort By:

1-8 of 8 online sources for Adrian Harel

  • View Online Source
    www.biospace.com/news_story.aspx?NewsEntityId=96191&Sou - [Cached Version]
    Published on: 5/12/2008    Last Visited: 5/14/2008  

    Prof. Schachner will collaborate with recently appointed CEO, Dr. Adrian Harel, in the ongoing Phase II Clinical trial on Hypotension in patients undergoing Cardio Artery Bypass Graft (CABG) patients and in designing future clinical trials.
    ...
    Dr. Adrian Harel joined Meditor in January 2008.He combines a broad scientific education with extensive industry experience.He holds a Ph.D. in Neurobiology, from the Weizmann Institute of Science, and was a postdoctoral at Washington University.Dr. Harel has many years of experience in the pharmaceutical and biotech industry.Dr. Harel has extensive Drug research & development know-how and GMP production and manufacturing knowledge.
    ...
    For all inquiries please contact Mr. Rafi Barkan, Chairman at +972 8 930 3307 or Dr. Adrian Harel, CEO at +972 8 930 3305.
    ...
    CONTACT: Mr. Rafi Barkan, Chairman, +972 8 930 3307; or Dr. Adrian Harel,

  • View Online Source
    www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=/w - [Cached Version]
    Published on: 5/12/2008    Last Visited: 5/13/2008  

    appointed CEO, Dr. Adrian Harel, in the ongoing Phase II Clinical trial on Hypotension in patients undergoing Cardio Artery Bypass Graft (CABG) patients and in designing future clinical trials.

    Dr. Adrian Harel joined Meditor in January 2008.He combines a broad scientific education with extensive industry experience.He holds a Ph.D. in Neurobiology, from the Weizmann Institute of Science, and was a postdoctoral at Washington University.Dr. Harel has many years of experience in the pharmaceutical and biotech industry.Dr. Harel has extensive Drug research & development know-how and GMP production and manufacturing knowledge.
    ...
    930 3307 or Dr. Adrian Harel, CEO at +972 8 930 3305.

  • View Online Source
    www.biospace.com/news_story.aspx?NewsEntityId=100020&So - [Cached Version]
    Published on: 6/11/2008    Last Visited: 6/12/2008  

    Dr. Adrian Harel, CEO of Meditor was quoted as saying: "We are planning to present these exciting results in an International Conference for Migraine in Europe.
    ...
    For all inquiries please contact Mr. Rafi Barkan, Chairman at +972 8 930 3307 or Dr. Adrian Harel, CEO at +972 8 930 3305.
    ...
    CONTACT: Mr. Rafi Barkan, Chairman, +972 8 930 3307, or Dr. Adrian Harel,

  • View Online Source
    www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/w - [Cached Version]
    Published on: 6/11/2008    Last Visited: 6/11/2008  

    Dr. Adrian Harel, CEO of Meditor was quoted as saying: "We are planning
    ...
    930 3307 or Dr. Adrian Harel, CEO at +972 8 930 3305.

  • View Online Source
    www.lifesciencesworld.com/news/view/73142?page=11 - [Cached Version]
    Last Visited: 8/8/2008  

    Dr. Adrian Harel, CEO of Meditor was quoted as saying: "We are planning to present these exciting results in an International Conference for Migraine in Europe.
    ...
    For all inquiries please contact Mr. Rafi Barkan, Chairman at +972 8 930 3307 or Dr. Adrian Harel, CEO at +972 8 930 3305.

  • View Online Source
    BioIsrael - [Cached Version]
    Published on: 5/1/2003    Last Visited: 2/4/2009  

    Heal-Or, a Ramat Gan startup, has developed a topical therapy that helps the body use its own proteins to speed up the wound healing process and prevent deterioration, says Adrian Harel, CEO.

  • View Online Source
    Meditor - About Us - Management - [Cached Version]
    Published on: 4/11/2009    Last Visited: 4/11/2009  

    Dr. Adrian Harel- (CEO)

    Dr. Adrian Harel joined Meditor in 2008. He combines a broad scientific education with extensive industry experience. He holds a Ph.D. in Neurobilogy, from the Weizmann Institute of Science, and was a postdoctoral at Washington University Dr. Harel many years of experience in the pharmaceutical and biotech industry (Interpharm, Proneuron, JBC, Heal-Or, Sepal Pharma and Molecular Cytomics). Dr. Harel has extensive Drug research & develpment know-how and GMP production and manufacturing knowledge.

  • View Online Source
    Meditor - News - [Cached Version]
    Published on: 6/11/2008    Last Visited: 4/11/2009  

    Dr. Adrian Harel, CEO of Meditor was quoted as saying: "We are planning to present these exciting results in an International Conference for Migraine in Europe.
    ...
    For more information on the company and its drug development activities, please visit www.meditorpharma.com For all inquiries please contact Mr. Rafi Barkan, Chairman at +972 8 930 3307 or Dr. Adrian Harel, CEO at +972 8 930 3305.
    ...
    Prof. Schachner will collaborate with recently appointed CEO, Dr. Adrian Harel, in the ongoing Phase II Clinical trial on Hypotension in patients undergoing Cardio Artery Bypass Graft (CABG) patients and in designing future clinical trials.
    ...
    Dr. Adrian Harel joined Meditor in January 2008. He combines a broad scientific education with extensive industry experience. He holds a Ph.D. in Neurobiology, from the Weizmann Institute of Science, and was a postdoctoral at Washington University. Dr. Harel has many years of experience in the pharmaceutical and biotech industry. Dr. Harel has extensive Drug research & development know-how and GMP production and manufacturing knowledge.
    ...
    For all inquiries please contact Mr. Rafi Barkan, Chairman at +972 8 930 3307 or Dr. Adrian Harel, CEO at +972 8 930 3305.

Wrong Person?

Try these instead
Related searches
More...

Copyright © 2009 Zoom Information Inc. All rights reserved.

BBeachHead-2009-11-09_RC001.1 OM13